Literature DB >> 19067969

The making of a melanocyte: the specification of melanoblasts from the neural crest.

Aaron J Thomas1, Carol A Erickson.   

Abstract

Melanocytes differentiate from the neural crest (NC), which is a transient population of cells that delaminates from the neural tube and migrates extensively throughout the embryo during vertebrate development. Melanoblast specification from NC precursors is a progressive process during which initially pluripotent cells become restricted to the melanogenic lineage and adopt the gene expression profile and morphology of melanocytes. This specification process is governed primarily by Wnt and BMP signaling molecules, although other signaling pathways, such as those activated by Kit and Endothelin 3, can also stimulate melanogenesis. The transcriptional repressor FoxD3 occupies a central role in melanocyte fate determination by repressing melanogenesis in premigratory NC cells and in other NC lineages.

Entities:  

Mesh:

Year:  2008        PMID: 19067969     DOI: 10.1111/j.1755-148X.2008.00506.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  64 in total

1.  Direct reprogramming of melanocytes to neural crest stem-like cells by one defined factor.

Authors:  Susan E Zabierowski; Valerie Baubet; Benjamin Himes; Ling Li; Mizuho Fukunaga-Kalabis; Sonal Patel; Ronan McDaid; Matt Guerra; Phyllis Gimotty; Nadia Dahmane; Nadia Dahamne; Meenhard Herlyn
Journal:  Stem Cells       Date:  2011-11       Impact factor: 6.277

Review 2.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

Review 3.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes.

Authors:  Igor Adameyko; Francois Lallemend
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

4.  Conditional immortalization establishes a repertoire of mouse melanocyte progenitors with distinct melanogenic differentiation potential.

Authors:  Ke Yang; Jin Chen; Wei Jiang; Enyi Huang; Jing Cui; Stephanie H Kim; Ning Hu; Hong Liu; Wenwen Zhang; Ruidong Li; Xiang Chen; Yuhan Kong; Jiye Zhang; Jinhua Wang; Linyuan Wang; Jikun Shen; Hue H Luu; Rex C Haydon; Xiaohua Lian; Tian Yang; Tong-Chuan He
Journal:  J Invest Dermatol       Date:  2012-05-17       Impact factor: 8.551

5.  FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

Authors:  Ethan V Abel; Andrew E Aplin
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

6.  Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma.

Authors:  Travis L Biechele; Nathan D Camp; Daniel M Fass; Rima M Kulikauskas; Nick C Robin; Bryan D White; Corinne M Taraska; Erin C Moore; Jeanot Muster; Rakesh Karmacharya; Stephen J Haggarty; Andy J Chien; Randall T Moon
Journal:  Chem Biol       Date:  2010-11-24

7.  Neural crest and Schwann cell progenitor-derived melanocytes are two spatially segregated populations similarly regulated by Foxd3.

Authors:  Erez Nitzan; Elise R Pfaltzgraff; Patricia A Labosky; Chaya Kalcheim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

8.  FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma.

Authors:  Michele B Weiss; Ethan V Abel; Neda Dadpey; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2014-07-24       Impact factor: 5.852

9.  Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.

Authors:  Hua Zhao; Daozhen Chen; Jiayuan Wang; Yongxiang Yin; Qiong Gao; Ye Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs.

Authors:  Yvonne Mica; Gabsang Lee; Stuart M Chambers; Mark J Tomishima; Lorenz Studer
Journal:  Cell Rep       Date:  2013-04-11       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.